Eprozinol
Appearance
Names | |
---|---|
IUPAC name
(RS)-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ECHA InfoCard | 100.046.482 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
Properties | |
C22H30N2O2 | |
Molar mass | 354.4858 |
Pharmacology | |
R03DX02 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Eprozinol is a drug for obstructive airway disease.[1][2]
References
- ^ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
- ^ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.